Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€63.70

€63.70

-1.380%
-0.88
-1.380%
€99.08
 
23.06.25 / Tradegate WKN: 853881 / Symbol: IFF / Name: IFF / Stock / Personal &Household Products & Services / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
JavaScript chart by amCharts 3.21.15
JavaScript chart by amCharts 3.21.15
JavaScript chart by amCharts 3.21.15JS chart by amCharts
Select a timeframe to show chart data
From: to:
Zoom:
Loading data...

Financial data and news for IFF

sharewise wants to provide you with the best news and tools for IFF, so we directly link to the best financial data sources.

News

Dividend Investors Looking for an Edge? 3 Stocks Insiders Bought: https://www.marketbeat.com/logos/articles/med_20250528153305_dividend-investors-looking-for-an-edge-3-stocks-in.png
Dividend Investors Looking for an Edge? 3 Stocks Insiders Bought

Investors are always seeking an edge, and insider purchases are one way to achieve it. Insider buying can highlight value plays and market bottoms that investors can bank on. If the stock in

IFF Opens New State-of-the-art Office in Hyderabad, India: https://mms.businesswire.com/media/20250623457977/en/2504307/5/Hero_image_reception.jpg
IFF Opens New State-of-the-art Office in Hyderabad, India


IFF (NYSE: IFF)--a global leader in flavors, fragrances, food ingredients, health and biosciences—has officially relocated its Global Business Services (GBS) center in Hyderabad to a newly

IFF Unveils Game-Changing Outlook on GLP-1 Consumers: https://mms.businesswire.com/media/20250604818126/en/2488480/5/GLP1_hero_visual.jpg
IFF Unveils Game-Changing Outlook on GLP-1 Consumers


IFF (NYSE: IFF), a global leader in food, beverage, and health and wellness, has released a new report highlighting how the rapidly growing GLP-1 consumer market is reshaping the sensory experience

IFF Pharma Solutions to Showcase Portfolio at Excipient World 2025: https://mms.businesswire.com/media/20250428283122/en/2451972/5/iStock-963142602.jpg
IFF Pharma Solutions to Showcase Portfolio at Excipient World 2025


IFF (NYSE: IFF) Pharma Solutions, a global leader in polymer innovations, will showcase its sustainable solutions at Excipient World 2025. The team will feature sustainable innovations

IFF Expands Pet Portfolio with Latest Science-driven Solutions: https://mms.businesswire.com/media/20250428408543/en/2450088/5/iStock-937244508.jpg
IFF Expands Pet Portfolio with Latest Science-driven Solutions


IFF (NYSE: IFF), a global powerhouse in bioscience and innovation, today announced a groundbreaking expansion of its pet portfolio. This launch marks a significant leap in IFF’s mission to

IFF Opens Dubai Creative Center With Perfumery Art Studio: https://mms.businesswire.com/media/20250415038625/en/2439359/5/IFF_Dubai_2025_opening.jpg
IFF Opens Dubai Creative Center With Perfumery Art Studio


IFF (NYSE: IFF) announced the inauguration of its Scent Dubai Creative Center, a 2,000-square-meter addition to the company’s facility in the Dubai Science Park Laboratory Complex. The added

IFF Unveils Cutting-Edge Citrus Innovation Center in Florida: https://mms.businesswire.com/media/20250409984035/en/2433986/5/Hero_shot.jpg
IFF Unveils Cutting-Edge Citrus Innovation Center in Florida


IFF (NYSE: IFF) today announced the opening of the Citrus Innovation Center in Lakeland, Florida, in partnership with Florida Polytechnic University. This 30,000 square foot facility encompasses

IFF Pharma Solutions Launches Low Nitrite METHOCEL™ HPMC for Nitrosamine Mitigation: https://mms.businesswire.com/media/20250408256574/en/2432604/5/Pharma_Low_Nitrite_METHOCELTM_For_Nitrosamine_Mitigation.jpg
IFF Pharma Solutions Launches Low Nitrite METHOCEL™ HPMC for Nitrosamine Mitigation


IFF (NYSE: IFF) Pharma Solutions, a global leader in polymer innovations, today announced the launch of Low Nitrite METHOCEL™ hydroxypropyl methylcellulose (HPMC), a range of low nitrite cellulose

IFF Introduces Science of Performance: A New Approach to Elevating Scent Design: https://mms.businesswire.com/media/20250401696884/en/2425779/5/Science_of_Performance_image_%282%29.jpg
IFF Introduces Science of Performance: A New Approach to Elevating Scent Design


IFF (NYSE: IFF) unveils its Science of Performance program, a comprehensive, science-driven suite that enhances fragrance creation by increasing efficiency and precision to manage scent intensity

IFF Appoints Virginia “Gina” Drosos to Board of Directors
IFF Appoints Virginia “Gina” Drosos to Board of Directors


IFF (NYSE: IFF)—a global leader in flavors, fragrances, food ingredients, health and biosciences—today announced the appointment of Gina Drosos to its board of directors, effective June 16. Drosos

IFF Announces Pricing of Tender Offers For Certain Outstanding Series of Notes
IFF Announces Pricing of Tender Offers For Certain Outstanding Series of Notes


IFF (NYSE: IFF) announced today the Total Consideration (as defined below) payable in connection with its previously announced tender offers to purchase for cash: (i) up to $1,100,000,000 aggregate

IFF Announces Early Tender Results and Increase of Tender Offers for Certain Outstanding Series of Notes
IFF Announces Early Tender Results and Increase of Tender Offers for Certain Outstanding Series of Notes


IFF (NYSE: IFF) announced today the early tender results for its tender offers to purchase for cash certain of its outstanding series of Notes.



IFF also announced it has increased the previously

IFF Completes Divestiture of Nitrocellulose Business
IFF Completes Divestiture of Nitrocellulose Business


IFF (NYSE: IFF) today announced that it has completed the divestiture of its nitrocellulose business, including Walsrode Industrial Park in lower Saxony, Germany, to Czechoslovak Group (CSG). The

IFF Reports First Quarter 2025 Results
IFF Reports First Quarter 2025 Results


IFF (NYSE: IFF) reported financial results for the first quarter ended March 31, 2025.



First Quarter 2025 Consolidated Summary:


Reported
(GAAP)


 


Adjusted
(Non-GAAP)1


Sales

IFF Announces Tender Offers for Certain Outstanding Series of Notes
IFF Announces Tender Offers for Certain Outstanding Series of Notes


IFF (NYSE: IFF) announced today the commencement of tender offers to purchase for cash certain of its outstanding series of notes listed in the tables below (collectively, the “Notes”) for an

IFF Declares Dividend for Second Quarter 2025
IFF Declares Dividend for Second Quarter 2025


IFF (NYSE: IFF) announced that its Board of Directors has declared a regular quarterly cash dividend of $0.40 per share of its common stock, payable on July 11, 2025 to shareholders of record as of

IFF Completes Divestiture of Pharma Solutions Business Unit
IFF Completes Divestiture of Pharma Solutions Business Unit


IFF (NYSE: IFF) today announced that it has successfully completed the previously announced divestiture of its Pharma Solutions business unit to Roquette.



“The completion of our Pharma Solutions

IFF Pharma Solutions to Showcase Plant-Based Dietary Supplement Ingredients and Technical Expertise at Vitafoods™ Europe 2025
IFF Pharma Solutions to Showcase Plant-Based Dietary Supplement Ingredients and Technical Expertise at Vitafoods™ Europe 2025


IFF (NYSE: IFF) Pharma Solutions is excited to announce its participation at Vitafoods™ Europe 2025, the premier global nutraceutical event. The team will showcase its cutting-edge dietary

IFF to Release First Quarter 2025 Results on May 6, 2025
IFF to Release First Quarter 2025 Results on May 6, 2025


IFF (NYSE:IFF) today announced that it will release its first quarter 2025 earnings results following the market close on Tuesday, May 6, 2025. The management team will host a live webcast on

IFF Opens Mexico Business Hub at Tecnoparque
IFF Opens Mexico Business Hub at Tecnoparque


To further strengthen its ability to serve customers with leading innovations, IFF (NYSE: IFF) announced it will combine the majority of its business operations in Mexico at a new site in Mexico

IFF and Kemira Form Joint Venture To Produce Sustainable Biobased Materials at Scale
IFF and Kemira Form Joint Venture To Produce Sustainable Biobased Materials at Scale


IFF (NYSE:IFF) and Kemira announced the formation of Alpha Bio, a joint venture aimed at commercial-scale production of renewable biobased materials. With an investment of approximately €130

IFF Declares Dividend for First Quarter 2025
IFF Declares Dividend for First Quarter 2025


IFF (NYSE: IFF) announced that its Board of Directors has declared a regular quarterly cash dividend of $0.40 per share of its common stock, payable on April 11, 2025 to shareholders of record as

IFF Announces Expansion of Cedar Rapids, Iowa Ingredients Facility
IFF Announces Expansion of Cedar Rapids, Iowa Ingredients Facility


IFF (NYSE: IFF) today unveiled plans to expand its Cedar Rapids, Iowa facility to capture a larger share of the booming healthy snacks market both in the U.S. and globally. The 47,000-square-foot

IFF Announces Executive Leadership Team Aligned With New Operating Model
IFF Announces Executive Leadership Team Aligned With New Operating Model


IFF (NYSE: IFF) announced changes to its executive leadership team, aligned with the Company’s external reporting structure.



After 21 years of dedicated service to IFF, Simon Herriott, president

IFF Reports Fourth Quarter and Full Year 2024 Results
IFF Reports Fourth Quarter and Full Year 2024 Results


International Flavors & Fragrances Inc. (NYSE: IFF) reported financial results for the fourth quarter and full year ended December 31, 2024.



Full year 2024 Consolidated Summary:


Reported



(